BRCA1/2 Mutation Analysis for Tumors

Next-generation sequencing assay to analyze mutations of all coding exons of the BRCA1 and BRCA2genes including point mutations and small insertions/deletions, which can lead to an increased risk of cancers, particularly breast and ovarian cancer. This test does not detect large deletions or duplications.

‍

Synonyms
Turnaround Time
14 days
Methodology
Molecular
Specimen Requirements

Formalin-fixed, paraffin-embedded(FFPE) tissue block (preferred, 40% tumor or more) or slides (1 H&E slide,plus 5-10 unstained slides cut at 5+ microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.

‍

Storage and Transportation

Use cold pack for transport. Make sure cold pack is not in direct contact with specimen.

CPT Codes
81163